verapamil has been researched along with Calcification, Pathologic in 7 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil pretreatment of the cells also inhibited matrix vesicle alkaline phosphatase activity and reduced the ability of these matrix vesicles to subsequently calcify on a type I collagen extracellular matrix scaffold." | 1.36 | Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. ( Chen, NX; Chen, X; Kircelli, F; Moe, SM; O'Neill, KD, 2010) |
| "Mibefradil doses were in the range of 0." | 1.30 | Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters. ( Dumont, L; Jasmin, G; Paquette, F, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, NX | 1 |
| Kircelli, F | 1 |
| O'Neill, KD | 1 |
| Chen, X | 1 |
| Moe, SM | 1 |
| Fleckenstein-Grün, G | 1 |
| Thimm, F | 1 |
| Frey, M | 1 |
| Matyas, S | 1 |
| Chatelain, P | 1 |
| Mouton, J | 1 |
| Feys, G | 1 |
| Laruel, A | 1 |
| Manning, AS | 1 |
| Mantovani, F | 1 |
| Patelli, E | 1 |
| Colombo, F | 1 |
| Paquette, F | 1 |
| Jasmin, G | 1 |
| Dumont, L | 1 |
| Yamashita, T | 1 |
| Kobayashi, A | 1 |
| Yamazaki, N | 1 |
| Miura, K | 1 |
| Shirasawa, H | 1 |
| Henry, PD | 1 |
1 review available for verapamil and Calcification, Pathologic
| Article | Year |
|---|---|
Atherosclerosis, calcium, and calcium antagonists.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cell Surv | 1985 |
6 other studies available for verapamil and Calcification, Pathologic
| Article | Year |
|---|---|
Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells.
Topics: Animals; Aorta, Thoracic; Calcification, Physiologic; Calcinosis; Calcium Channel Blockers; Calcium | 2010 |
Progression and regression by verapamil of vitamin D3-induced calcific medial degeneration in coronary arteries of rats.
Topics: Animals; Arteriosclerosis; Calcinosis; Calcium; Calcium Channel Blockers; Cholecalciferol; Coronary | 1995 |
Vascular calcium overload produced by vitamin D3, in rats. Effect of treatment with SR 33805, a novel calcium entry blocker.
Topics: Animals; Aorta, Thoracic; Calcinosis; Calcium; Calcium Channel Blockers; Cardiovascular Diseases; Ch | 1995 |
[Correction of acquired penile curvatures].
Topics: Calcinosis; Fibrosis; Humans; Male; Penile Induration; Penile Prosthesis; Penis; Prosthesis Design; | 1998 |
Cardioprotective efficacy of verapamil and mibefradil in young UM-X7.1 cardiomyopathic hamsters.
Topics: Animals; Biomarkers; Calcinosis; Calcium Channel Blockers; Cardiomyopathies; Cardiovascular Agents; | 1999 |
Effects of L-carnitine and verapamil on myocardial carnitine concentration and histopathology of Syrian hamster BIO 14.6.
Topics: Animals; Calcinosis; Cardiomyopathies; Carnitine; Cricetinae; Fibrosis; Mesocricetus; Myocardium; Ne | 1986 |